hyoscyamine sulfate 0.12 MG / methenamine 81 MG / methylene blue 10.8 MG / phenyl salicylate 32.4 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet

RxCUI
1048336
RxNorm name
hyoscyamine sulfate 0.12 MG / methenamine 81 MG / methylene blue 10.8 MG / phenyl salicylate 32.4 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet
Display name
Hyoscyamine/Methenamine/Methylene blue/Phenyl salicylate/Sodium phosphate, monobasic (Oral Pill)
Full name
hyoscyamine sulfate 0.12 MG / methenamine 81 MG / methylene blue 10.8 MG / phenyl salicylate 32.4 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet
Term type
SCD
Status
Active
Strength
0.12-81-10.8-32.4-40.8 mg
Dose form
Tab
Route
Oral Pill
Updated
2026-08-03 17:30:45

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
012011
Active start
012011
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
hyoscyamine sulfate0.12 MG / 1 EACHhyoscyaminehyoscyamine sulfate
sodium phosphate, monobasic40.8 MG / 1 EACHsodium phosphate, monobasicsodium phosphate, monobasic
phenyl salicylate32.4 MG / 1 EACHphenyl salicylatephenyl salicylate
methenamine81 MG / 1 EACHmethenaminemethenamine
methylene blue10.8 MG / 1 EACHmethylene bluemethylene blue

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Tablet317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
hyoscyamine153970
sodium phosphate, monobasic235496
phenyl salicylate36122
methenamine6832
methylene blue6878

Source Vocabulary Codes#

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 7 matching rows.

NDC11, Source, Active table
NDC11SourceActive
42291085190rxnav_ndcsyes
58657045790rxnav_ndcsyes
58657045890rxnav_ndcsyes
71186000024rxnav_ndcsyes
15338050209rxnav_historical
66663021901rxnav_historical_indirect
68032028190rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
URELLEHYOSCYAMINE SULFATE, METHENAMINE, METHYLENE BLUE, PHENYL SALICYLATE, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATEViatris Specialty LLC1d80a11c-6f86-403b-85d4-32ec1924dbe92015-01-13Warnings, Adverse reactionsExact identifier
rxcui: 1048336

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
1d80a11c-6f86-403b-85d4-32ec1924dbe9methenamine 81 MG / sodium phosphate, monobasic 40.8 MG / phenyl salicylate 32.4 MG / methylene blue 10.8 MG / hyoscyamine sulfate 0.12 MG Oral TabletPSN4URELLE ® Urinary Antiseptic20150113
1d80a11c-6f86-403b-85d4-32ec1924dbe9hyoscyamine sulfate 0.12 MG / methenamine 81 MG / methylene blue 10.8 MG / phenyl salicylate 32.4 MG / sodium phosphate, monobasic 40.8 MG Oral TabletSCD4URELLE ® Urinary Antiseptic20150113
02f19c91-9d39-4843-b6a4-25d81280b067hyoscyamine sulfate 0.12 MG / methenamine 81 MG / methylene blue 10.8 MG / phenyl salicylate 32.4 MG / sodium phosphate, monobasic 40.8 MG Oral TabletSCD2VILEVEV MB Tablets20190221
02f19c91-9d39-4843-b6a4-25d81280b067methenamine 81 MG / sodium phosphate, monobasic 40.8 MG / phenyl salicylate 32.4 MG / methylene blue 10.8 MG / hyoscyamine sulfate 0.12 MG Oral TabletPSN2VILEVEV MB Tablets20190221
6cbeb7be-397b-819f-e053-2a91aa0a208emethenamine 81 MG / sodium phosphate, monobasic 40.8 MG / phenyl salicylate 32.4 MG / methylene blue 10.8 MG / hyoscyamine sulfate 0.12 MG Oral TabletPSN2UroAv-81 Tablets (Product contract packaged by Apace Packaging, LLC)20180521
6cbeb7be-397b-819f-e053-2a91aa0a208ehyoscyamine sulfate 0.12 MG / methenamine 81 MG / methylene blue 10.8 MG / phenyl salicylate 32.4 MG / sodium phosphate, monobasic 40.8 MG Oral TabletSCD2UroAv-81 Tablets (Product contract packaged by Apace Packaging, LLC)20180521

DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
370dc1da-b45a-008b-e054-00144ff8d46cURO-458 TabletsMethod Pharmaceuticals, LLC20231211
0f72ec4b-5fd4-5379-c0ab-b008c0d8518dUroAv-81 TabletsAvKARE20200120
02f19c91-9d39-4843-b6a4-25d81280b067VILEVEV MB TabletsVilvet Pharmaceuticals Inc20190221
6cbeb7be-397b-819f-e053-2a91aa0a208eUroAv-81 Tablets (Product contract packaged by Apace Packaging, LLC)Apace Packaging, LLC | Apertus Pharmaceuticals, LLC20180521
d2c713c4-4266-445d-b806-d318f6dd6469National Council for Prescription Drug Programs20120724

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCV03ABAntidotesATC1-4methylene blue
ATCA03BABelladonna alkaloids, tertiary aminesATC1-4hyoscyamine
ATCJ01XXOther antibacterialsATC1-4methenamine
ATCG04BXOther urologicalsATC1-4phenyl salicylate
ATCV04CGTests for gastric secretionATC1-4methylene blue
MEDRTD064692HyoscyamineCHEMhas_ingredienthyoscyamine sulfate
MEDRTD064692HyoscyamineCHEMhas_ingredienthyoscyamine
MEDRTD008709MethenamineCHEMhas_ingredientmethenamine
MEDRTD008751Methylene BlueCHEMhas_ingredientmethylene blue
MEDRTD010710PhosphatesCHEMhas_ingredientsodium phosphate, monobasic
MEDRTD012459SalicylatesCHEMhas_ingredientphenyl salicylate
MEDRTD013449SulfonamidesCHEMci_chemclassmethenamine
MEDRTD000014Abnormalities, Drug-InducedDISEASEmay_treathyoscyamine sulfate
MEDRTD000014Abnormalities, Drug-InducedDISEASEmay_treathyoscyamine
MEDRTD000471AlkalosisDISEASEci_withsodium phosphate, monobasic
MEDRTD001437BacteriuriaDISEASEmay_treatmethenamine
MEDRTD003085ColicDISEASEmay_treathyoscyamine
MEDRTD003085ColicDISEASEmay_treathyoscyamine sulfate
MEDRTD003093Colitis, UlcerativeDISEASEci_withhyoscyamine
MEDRTD003093Colitis, UlcerativeDISEASEci_withhyoscyamine sulfate
MEDRTD003248ConstipationDISEASEmay_treatsodium phosphate, monobasic
MEDRTD003490CyanosisDISEASEmay_treatmethylene blue
MEDRTD003490CyanosisDISEASEmay_preventmethylene blue
MEDRTD003556CystitisDISEASEmay_treatmethenamine
MEDRTD003681DehydrationDISEASEci_withmethenamine
MEDRTD004342Drug HypersensitivityDISEASEci_withmethylene blue
MEDRTD004342Drug HypersensitivityDISEASEci_withhyoscyamine
MEDRTD004342Drug HypersensitivityDISEASEci_withhyoscyamine sulfate
MEDRTD004342Drug HypersensitivityDISEASEci_withphenyl salicylate
MEDRTD004342Drug HypersensitivityDISEASEci_withsodium phosphate, monobasic
MEDRTD004487EdemaDISEASEci_withsodium phosphate, monobasic
MEDRTD004927Escherichia coli InfectionsDISEASEmay_treatmethenamine
MEDRTD005334FeverDISEASEmay_treatphenyl salicylate
MEDRTD018589GastroparesisDISEASEinduceshyoscyamine
MEDRTD018589GastroparesisDISEASEinduceshyoscyamine sulfate
MEDRTD005901GlaucomaDISEASEci_withhyoscyamine
MEDRTD005901GlaucomaDISEASEci_withhyoscyamine sulfate
MEDRTD048550Hepatic InsufficiencyDISEASEci_withmethenamine
MEDRTD006561Herpes SimplexDISEASEmay_treatmethylene blue
MEDRTD006945HyperhidrosisDISEASEmay_treathyoscyamine
MEDRTD006945HyperhidrosisDISEASEmay_treathyoscyamine sulfate
MEDRTD006955HypernatremiaDISEASEci_withsodium phosphate, monobasic
MEDRTD006967HypersensitivityDISEASEci_withmethenamine
MEDRTD006996HypocalcemiaDISEASEci_withsodium phosphate, monobasic
MEDRTD017674HypophosphatemiaDISEASEmay_preventsodium phosphate, monobasic
MEDRTD017674HypophosphatemiaDISEASEmay_treatsodium phosphate, monobasic
MEDRTD007077Ileal DiseasesDISEASEci_withhyoscyamine
MEDRTD007077Ileal DiseasesDISEASEci_withhyoscyamine sulfate
MEDRTD007415Intestinal ObstructionDISEASEci_withhyoscyamine
MEDRTD007415Intestinal ObstructionDISEASEci_withhyoscyamine sulfate
MEDRTD007431Intraoperative ComplicationsDISEASEmay_treathyoscyamine sulfate
MEDRTD007431Intraoperative ComplicationsDISEASEmay_treathyoscyamine
MEDRTD043183Irritable Bowel SyndromeDISEASEmay_treathyoscyamine
MEDRTD043183Irritable Bowel SyndromeDISEASEmay_treathyoscyamine sulfate
MEDRTD007674Kidney DiseasesDISEASEci_withmethenamine
MEDRTD020347LithiasisDISEASEmay_treatmethylene blue
MEDRTD008532Megacolon, ToxicDISEASEci_withhyoscyamine sulfate
MEDRTD008532Megacolon, ToxicDISEASEci_withhyoscyamine
MEDRTD008708MethemoglobinemiaDISEASEmay_treatmethylene blue
MEDRTD008708MethemoglobinemiaDISEASEinducesmethylene blue
MEDRTD009127Muscle RigidityDISEASEmay_treathyoscyamine sulfate
MEDRTD009127Muscle RigidityDISEASEmay_treathyoscyamine
MEDRTD009157Myasthenia GravisDISEASEci_withhyoscyamine sulfate
MEDRTD009157Myasthenia GravisDISEASEci_withhyoscyamine
MEDRTD017202Myocardial IschemiaDISEASEci_withhyoscyamine
MEDRTD017202Myocardial IschemiaDISEASEci_withhyoscyamine sulfate
MEDRTD010146PainDISEASEmay_preventphenyl salicylate
MEDRTD010146PainDISEASEmay_treatphenyl salicylate
MEDRTD010437Peptic UlcerDISEASEmay_treathyoscyamine sulfate
MEDRTD010437Peptic UlcerDISEASEmay_treathyoscyamine
MEDRTD011041PoisoningDISEASEmay_treatmethylene blue
MEDRTD011247PregnancyDISEASEci_withmethylene blue
MEDRTD011654Pulmonary EdemaDISEASEci_withsodium phosphate, monobasic
MEDRTD051437Renal InsufficiencyDISEASEci_withsodium phosphate, monobasic
MEDRTD051437Renal InsufficiencyDISEASEci_withmethylene blue
MEDRTD012220RhinitisDISEASEmay_treathyoscyamine sulfate
MEDRTD012220RhinitisDISEASEmay_treathyoscyamine
MEDRTD012771Shock, HemorrhagicDISEASEci_withhyoscyamine
MEDRTD012771Shock, HemorrhagicDISEASEci_withhyoscyamine sulfate
MEDRTD012798SialorrheaDISEASEmay_treathyoscyamine
MEDRTD012798SialorrheaDISEASEmay_treathyoscyamine sulfate
MEDRTD013035SpasmDISEASEmay_treathyoscyamine
MEDRTD013035SpasmDISEASEmay_treathyoscyamine sulfate
MEDRTD013203Staphylococcal InfectionsDISEASEmay_treatmethenamine
MEDRTD014202TremorDISEASEmay_treathyoscyamine
MEDRTD014202TremorDISEASEmay_treathyoscyamine sulfate
MEDRTD014524Urethral ObstructionDISEASEci_withhyoscyamine
MEDRTD014524Urethral ObstructionDISEASEci_withhyoscyamine sulfate
MEDRTD001750Urinary Bladder, NeurogenicDISEASEmay_treathyoscyamine sulfate
MEDRTD001750Urinary Bladder, NeurogenicDISEASEmay_treathyoscyamine
MEDRTD014552Urinary Tract InfectionsDISEASEmay_preventmethenamine
MEDRTD014552Urinary Tract InfectionsDISEASEmay_treatmethylene blue
MEDRTD020924Urological ManifestationsDISEASEmay_treatsodium phosphate, monobasic
MEDRTD014987XerostomiaDISEASEinduceshyoscyamine
MEDRTD014987XerostomiaDISEASEinduceshyoscyamine sulfate
MEDRTN0000000236Alkylating ActivityMOAhas_moamethylene blue
MEDRTN0000175355Binding ActivityMOAhas_moamethylene blue
MEDRTN0000000125Cholinergic Muscarinic AntagonistsMOAhas_moahyoscyamine
MEDRTN0000000125Cholinergic Muscarinic AntagonistsMOAhas_moahyoscyamine sulfate
MEDRTN0000000160Cyclooxygenase InhibitorsMOAhas_moaphenyl salicylate
MEDRTN0000000220Electrolyte ActivityMOAhas_moasodium phosphate, monobasic
MEDRTN0000000207Histamine Receptor AntagonistsMOAhas_moahyoscyamine sulfate
MEDRTN0000000207Histamine Receptor AntagonistsMOAhas_moahyoscyamine
MEDRTN0000010288Osmotic ActivityMOAhas_moasodium phosphate, monobasic
MEDRTN0000000130Serotonin AntagonistsMOAhas_moahyoscyamine
MEDRTN0000000130Serotonin AntagonistsMOAhas_moahyoscyamine sulfate
MEDRTN0000008331Cardiovascular Activity AlterationPEhas_pehyoscyamine
MEDRTN0000008331Cardiovascular Activity AlterationPEhas_pehyoscyamine sulfate
MEDRTN0000008337Cellular Activity AlterationPEhas_pesodium phosphate, monobasic
MEDRTN0000008337Cellular Activity AlterationPEhas_pemethenamine
MEDRTN0000008337Cellular Activity AlterationPEhas_pemethylene blue
MEDRTN0000008832Decreased Platelet AggregationPEhas_pephenyl salicylate
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_pephenyl salicylate
MEDRTN0000008868Decreased Respiratory SecretionsPEhas_pehyoscyamine
MEDRTN0000008868Decreased Respiratory SecretionsPEhas_pehyoscyamine sulfate
MEDRTN0000009006Decreased Thromboxane ProductionPEhas_pephenyl salicylate
MEDRTN0000009371Increased Large Intestinal MotilityPEhas_pesodium phosphate, monobasic
MEDRTN0000009399Increased Metabolic RatePEhas_pemethylene blue
MEDRTN0000009782Oxygen Carrying Capacity AlterationPEhas_pemethylene blue
MEDRTN0000009845Small Intestine Fluid/Electrolyte Absorption AlterationPEhas_pesodium phosphate, monobasic

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.12 MG / 81 MG / 10.8 MG / 32.4 MG / 40.8 MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
ATTRIBUTESTTYSCD
CODESMMSL_CODEBD30291
CODESMMSL_CODEBD8804
CODESMMSL_CODECD30291
CODESMMSL_CODECD8804
CODESRxCUI1048336
CODESVUID4026587
NAMESPrescribable Synonymmethenamine 81 MG / sodium phosphate, monobasic 40.8 MG / phenyl salicylate 32.4 MG / methylene blue 10.8 MG / hyoscyamine sulfate 0.12 MG Oral Tablet
NAMESRXNAV_STRhyoscyamine sulfate 0.12 MG / methenamine 81 MG / methylene blue 10.8 MG / phenyl salicylate 32.4 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet
NAMESRxNorm Namehyoscyamine sulfate 0.12 MG / methenamine 81 MG / methylene blue 10.8 MG / phenyl salicylate 32.4 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet
SOURCESSourceGold Standard Alchemy
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceVeterans Health Administration National Drug File